口腔癌和糖尿病的突变景观和功能洞察:一个比较的视角
1School of Chemical and Biotechnology, SASTRA Deemed to be University, Thirumalaisamudram, Thanjavur, Tamil Nadu 613401, India.
Computational biology and chemistry
|December 9, 2025
概括
这项研究比较了口腔癌和糖尿病的遗传变异,发现了共享和独特的突变特征. 这些发现提供了关于将代谢功能障碍与癌症发展联系在一起的分子机制的见解.
科学领域:
- 基因组学就是基因组学.
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 口腔癌和糖尿病共享氧化应激和线粒体功能障碍等机制.
- 以前的研究表明,糖尿病可能通过IRS-1/FAK通路影响口腔癌风险.
- 这些条件的比较突变格局尚未得到充分理解.
研究的目的:
- 在口腔癌和糖尿病中比较线粒体和核变异.
- 为了确定共享和独特的突变配置文件.
- 探索这些变体的功能影响.
主要方法:
- 对公共基因组数据集 (GEO) 和线粒体序列的分析.
- 使用GATK Mutect2进行变体调用,使用BCFtools进行过,并使用SnpEff进行注释.
- 使用ShinyGO与KEGG映射进行路径丰富分析.
主要成果:
- 确定了49种功能性显著的线粒体变异 (MT-ATP8,MT-ATP6,MT-ND3,MT-ND5基因).
- 发现了10974种具有显著功能影响的核变体.
- 突出了代谢压力,线粒体功能障碍和瘤性途径之间的潜在联系.
结论:
- 这项研究揭示了口腔癌和糖尿病的融合和疾病特异性突变特征.
- 强调公共数据集的实用性,用于识别功能变体.
- 建议在更大的患者队伍中进一步验证这些变体是有必要的.
相关概念视频
Loss of Tumor Suppressor Gene Functions
5.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.8K
Cancer
53.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.4K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Cancers Originate from Somatic Mutations in a Single Cell
14.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.5K


